Pandemic potential of avian influenza A (H7N9) viruses

Trends in Microbiology

Volumn 22, Issue 11, 2014, Pages 623-631

  Watanabe, Tokiko ^a,b,c   Watanabe, Shinji ^b,d   Maher, Eileen A ^a   Neumann, Gabriele ^a   Kawaoka, Yoshihiro ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Avian influenza H7N9 viruses; Pandemic potential; Transmission

Indexed keywords

AMINO ACID; HEMAGGLUTININ; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

CHINA; CLINICAL FEATURE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RATE; INFECTION RISK; INFLUENZA VIRUS A H7N9; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; RISK ASSESSMENT; VIRUS DETECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; AVIAN INFLUENZA; BIRD; DISEASE TRANSMISSION; FERRET; GROWTH, DEVELOPMENT AND AGING; GUINEA PIG; INFLUENZA A VIRUS (H7N9); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; ORTHOMYXOVIRUS INFECTION; PANDEMIC; PATHOGENICITY; TRANSMISSION; VETERINARY; VIROLOGY; ZOONOSIS;

AVES; AVIAN INFLUENZA VIRUS; CAVIA; INFLUENZA A VIRUS; MAMMALIA; MUSTELA; ORTHOMYXOVIRIDAE;

ANIMALS; BIRDS; CHINA; DISEASE TRANSMISSION, INFECTIOUS; FERRETS; GUINEA PIGS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; ZOONOSES;

EID: 84924861782     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.08.008     Document Type: Review

References (115)

1. Orthomyxoviruses 2013, Lippincott Williams & Wilkins. P.F. Wright (Ed.).
2. Tong S., et al. A distinct lineage of influenza A virus from bats. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:4269-4274.
3. Tong S., et al. New world bats harbor diverse influenza a viruses. PLoS Pathog. 2013, 9:e1003657.
4. Beare A.S., Webster R.G. Replication of avian influenza viruses in humans. Arch. Virol. 1991, 119:37-42.
5. Hinshaw V.S., et al. Are seals frequently infected with avian influenza viruses?. J. Virol. 1984, 51:863-865.
6. Murphy B.R., et al. Avian-human reassortant influenza A viruses derived by mating avian and human influenza A viruses. J. Infect. Dis. 1984, 150:841-850.
7. Webster R.G., et al. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 1978, 84:268-278.
8. Emergence of avian influenza A (H7N9) virus causing severe human illness - China, February-April 2013. MMWR Morb. Mortal. Wkly. Rep. 2013, 62:366-371. Centers for Disease Control and Prevention.
9. Shi J.Z., et al. Isolation and characterization of H7N9 viruses from live poultry markets - implication of the source of current H7N9 infection in humans. Chin. Sci. Bull. 2013, 58:1857-1863.
10. Han J., et al. Epidemiological link between exposure to poultry and all influenza A (H7N9) confirmed cases in Huzhou city, China, March to May 2013. Euro Surveill. 2013, 18. pii=20481.
11. Chen Y., et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013, 381:1916-1925.
12. Wang C., et al. Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. J. Infect. Dis. 2014, 209:34-37.
13. Liu T., et al. One family cluster of avian influenza A (H7N9) virus infection in Shandong, China. BMC Infect. Dis. 2014, 14:98.
14. Murhekar M., et al. Avian influenza A (H7N9) and the closure of live bird markets. Western Pac. Surveill. Response J. 2013, 4:4-7.
15. Xu J., et al. Reducing exposure to avian influenza H7N9. Lancet 2013, 381:1815-1816.
16. Yu H., et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet 2014, 383:541-548.
17. Chowell G., et al. Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Med. 2013, 11:214.
18. Chen E., et al. Human infection with avian influenza A (H7N9) virus re-emerges in China in winter 2013. Euro Surveill. 2013, 18. pii: 20616.
19. Lu S., et al. Prognosis of 18 H7N9 avian influenza patients in Shanghai. PLoS ONE 2014, 9:e88728.
20. Ding H., et al. Epidemiologic characterization of 30 confirmed cases of human infection with avian influenza A (H7N9) virus in Hangzhou, China. BMC Infect. Dis. 2014, 14:175.
21. Wang X.F., et al. Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai. Clin. Respir. J. 2013, 10.1111/crj.12087.
22. Wang C., et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin. Infect. Dis. 2014, 58:1095-1103.
23. Gao H.N., et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N. Engl. J. Med. 2013, 368:2277-2285.
24. Dudley J.P., Mackay I.M. Age-specific and sex-specific morbidity and mortality from avian influenza A (H7N9). J. Clin. Virol. 2013, 58:568-570.
25. Liu S., et al. Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China. J. Infect. 2013, 67:595-605.
26. Ji H., et al. Epidemiological and clinical characteristics and risk factors for death of patients with avian influenza A H7N9 virus infection from Jiangsu Province, Eastern China. PLoS ONE 2014, 9:e89581.
27. Li Q., et al. Epidemiology of human infections with avian influenza A (H7N9) virus in China. N. Engl. J. Med. 2014, 370:520-532.
28. Zhang W., et al. Epidemiologic characteristics of cases for influenza A (H7N9) virus infections in China. Clin. Infect. Dis. 2013, 57:619-620.
29. Cowling B.J., et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 2013, 382:129-137.
30. Tang X., et al. ARDS associated with pneumonia caused by avian influenza A H7N9 virus treated with extracorporeal membrane oxygenation. Clin. Respir. J. 2014, 10.1111/crj.12140.
31. Chen E., et al. The first avian influenza A (H7N9) viral infection in humans in Zhejiang Province, China: a death report. Front. Med. 2013, 7:333-344.
32. Xie L., et al. Clinical and epidemiological survey and analysis of the first case of human infection with avian influenza A (H7N9) virus in Hangzhou, China. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32:1617-1620.
33. Gao R., et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 2013, 368:1888-1897.
34. Wang Q., et al. Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings. Radiology 2013, 268:882-889.
35. Yu L., et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A (H7N9) virus. Clin. Infect. Dis. 2013, 57:1449-1457.
36. Li J., et al. Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human. Sci. China Life Sci. 2013, 56:485-492.
37. Mei Z., et al. Avian influenza A (H7N9) virus infections, Shanghai, China. Emerg. Infect. Dis. 2013, 19:1179-1181.
38. To K.K., et al. Unique reassortant of influenza A (H7N9) virus associated with severe disease emerging in Hong Kong. J. Infect. 2014, 69:60-68.
39. Lu S., et al. Clinical findings for early human cases of influenza A (H7N9) virus infection, Shanghai, China. Emerg. Infect. Dis. 2013, 19:1142-1146.
40. Ai J., et al. Case-control study of risk factors for human infection with influenza A (H7N9) virus in Jiangsu Province, China, 2013. Euro Surveill. 2013, 18:20510.
41. Bao C.J., et al. Live-animal markets and influenza A (H7N9) virus infection. N. Engl. J. Med. 2013, 368:2337-2339.
42. Sun J., et al. Comparison of characteristics between patients with H7N9 living in rural and urban areas of Zhejiang Province, China: a preliminary report. PLoS ONE 2014, 9:e93775.
43. Yang P., et al. A case of avian influenza A (H7N9) virus occurring in the summer season, China. J. Infect. 2013, 67:624-625.
44. Lv H., et al. Mild illness in avian influenza A (H7N9) virus-infected poultry worker, Huzhou, China, April 2013. Emerg. Infect. Dis. 2013, 19:1885-1888.
45. Yang S., et al. Avian-origin influenza A (H7N9) infection in influenza A (H7N9)-affected areas of China: a serological study. J. Infect. Dis. 2014, 209:265-269.
46. Ip D.K., et al. Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ 2013, 346:f3693.
47. Yang P., et al. Surveillance for avian influenza A (H7N9), Beijing, China, 2013. Emerg. Infect. Dis. 2013, 19:2041-2043.
48. Yu H., et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 2013, 382:138-145.
49. Cowling B.J., et al. Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A (H7N9) infections in China, March to April 2013. Euro Surveill. 2013, 18:20475.
50. Jie Z., et al. Family outbreak of severe pneumonia induced by H7N9 infection. Am. J. Respir. Crit. Care Med. 2013, 188:114-115.
51. Qi X., et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ 2013, 347:f4752.
52. Liu D., et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 2013, 381:1926-1932.
53. Lam T.T., et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 2013, 502:241-244.
54. Kageyama T., et al. Genetic analysis of novel avian A (H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 2013, 18:20453.
55. Wu A., et al. Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe 2013, 14:446-452.
56. Cui L., et al. Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus. Nat. Commun. 2014, 5:3142.
57. Zhang L., et al. Rapid reassortment of internal genes in avian influenza A (H7N9) virus. Clin. Infect. Dis. 2013, 57:1059-1061.
58. Neumann G., et al. Identification of amino acid changes that may have been critical for the genesis of A (H7N9) influenza viruses. J. Virol. 2014, 88:4877-4896.
59. Meng Z., et al. Possible pandemic threat from new reassortment of influenza A (H7N9) virus in China. Euro Surveill. 2014, 19. pii:20699.
60. Yu X., et al. Influenza H7N9 and H9N2 viruses: coexistence in poultry linked to human H7N9 infection and genome characteristics. J. Virol. 2014, 88:3423-3431.
61. Han J., et al. Cocirculation of three hemagglutinin and two neuraminidase subtypes of avian influenza viruses in Huzhou, China, April 2013: implication for the origin of the novel H7N9 virus. J. Virol. 2014, 88:6506-6511.
62. Liu J., et al. Complex reassortment of polymerase genes in Asian influenza A virus H7 and H9 subtypes. Infect. Genet. Evol. 2014, 23:203-208.
63. de Graaf M., Fouchier R.A. Role of receptor binding specificity in influenza A virus transmission and pathogenesis. EMBO J. 2014, 33:823-841.
64. Rogers G.N., et al. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 1983, 304:76-78.
65. Xu R., et al. Preferential recognition of avian-like receptors in human influenza A H7N9 viruses. Science 2013, 342:1230-1235.
66. Tharakaraman K., et al. Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell 2013, 153:1486-1493.
67. Zhou J., et al. Biological features of novel avian influenza A (H7N9) virus. Nature 2013, 499:500-503.
68. Watanabe T., et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 2013, 501:551-555.
69. Dortmans J.C., et al. Adaptation of novel H7N9 influenza A virus to human receptors. Sci. Rep. 2013, 3:3058.
70. Yang H., et al. Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus. J. Virol. 2013, 87:12433-12446.
71. Ramos I., et al. H7N9 influenza viruses interact preferentially with alpha2,3-linked sialic acids and bind weakly to alpha2,6-linked sialic acids. J. Gen. Virol. 2013, 94:2417-2423.
72. Belser J.A., et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 2013, 501:556-559.
73. Zhang Q., et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 2013, 341:410-414.
74. Xiong X., et al. Receptor binding by an H7N9 influenza virus from humans. Nature 2013, 499:496-499.
75. Shi Y., et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 2013, 342:243-247.
76. Hatta M., et al. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001, 293:1840-1842.
77. Labadie K., et al. Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology 2007, 362:271-282.
78. Rameix-Welti M.A., et al. Avian influenza A virus polymerase association with nucleoprotein, but not polymerase assembly, is impaired in human cells during the course of infection. J. Virol. 2009, 83:1320-1331.
79. Moncorge O., et al. Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase. J. Virol. 2010, 84:9978-9986.
80. Mehle A., Doudna J.A. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 2008, 4:111-122.
81. Foeglein A., et al. Influence of PB2 host-range determinants on the intranuclear mobility of the influenza A virus polymerase. J. Gen. Virol. 2011, 92:1650-1661.
82. Prinzinger R., et al. Body-temperature in birds. Comp. Biochem. Phys. A 1991, 99:499-506.
83. Hatta M., et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 2007, 3:1374-1379.
84. Massin P., et al. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J. Virol. 2001, 75:5398-5404.
85. Van Hoeven N., et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3366-3371.
86. Steel J., et al. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 2009, 5:e1000252.
87. Watanabe T., et al. Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential. Cell Host Microbe 2014, 15:692-705.
88. Jonges M., et al. Emergence of the virulence-associated PB2 E627K substitution in a fatal human case of highly pathogenic avian influenza virus A (H7N7) infection as determined by Illumina ultra-deep sequencing. J. Virol. 2014, 88:1694-1702.
89. Li Z., et al. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J. Virol. 2005, 79:12058-12064.
90. Mok C.K., et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J. Virol. 2014, 88:3568-3576.
91. Yamada S., et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog. 2010, 6:e1001034.
92. Mehle A., Doudna J.A. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21312-21316.
93. Kim J.H., et al. Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice. J. Gen. Virol. 2010, 91:1284-1289.
94. Bussey K.A., et al. PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells. J. Virol. 2011, 85:7020-7028.
95. Mehle A., et al. Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers. J. Virol. 2012, 86:1750-1757.
96. Yamayoshi S., et al. Virulence-affecting amino acid changes in the PA protein of H7N9 influenza A viruses. J. Virol. 2014, 88:3127-3134.
97. Liu Q., et al. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes Infect. 2013, 15:432-439.
98. Xu W., et al. PA-356R is a unique signature of the avian influenza A (H7N9) viruses with bird-to-human transmissibility: potential implication for animal surveillances. J. Infect. 2013, 67:490-494.
99. Zhu H., et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 2013, 341:183-186.
100. Richard M., et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 2013, 501:560-563.
101. Gabbard J.D., et al. Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model. J. Virol. 2014, 88:1502-1512.
102. Hai R., et al. Influenza A (H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat. Commun. 2013, 4:2854.
103. Xu L., et al. Novel avian-origin human influenza A (H7N9) can be transmitted between ferrets via respiratory droplets. J. Infect. Dis. 2014, 209:551-556.
104. Imai M., et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012, 486:420-428.
105. Pantin-Jackwood M.J., et al. Role of poultry in the spread of novel H7N9 influenza virus in China. J. Virol. 2014, 88:5381-5390.
106. Wu Y., et al. Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res. 2013, 23:1347-1355.
107. Hu Y., et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013, 381:2273-2279.
108. Yen H.L., et al. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population. MBio 2013, 4:e00396-e413.
109. Lin P.H., et al. Virological, serological, and antiviral studies in an imported human case of avian influenza A (H7N9) virus in Taiwan. Clin. Infect. Dis. 2014, 58:242-246.
110. Shen Z., et al. Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection. Clin. Microbiol. Infect. 2013, 20:O493-O500.
111. Govorkova E.A. Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses. Influenza Other Respir. Viruses 2013, 7(Suppl 1):50-57.
112. Bloom J.D., et al. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010, 328:1272-1275.
113. Imai M., et al. Transmission of influenza A/H5N1 viruses in mammals. Virus Res. 2013, 178:15-20.
114. Zhu Y., et al. Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China. Lancet 2013, 381:2134.
115. Guo L., et al. Human antibody responses to avian influenza A (H7N9) virus, 2013. Emerg. Infect. Dis. 2014, 20:192-200.